• AbbVie’s Imbruvica is First Approved Treatment for Adults with Chronic Graft-Versus-Host-Disease
  • Sancilio Completes Enrollment in Clinical Trial of Altemia as Treatment for Children with Sickle Cell Conditions
  • Gamida Cell Receives $3.5M Grant from Israeli Government to Help Develop CordIn Therapy
  • ‘Natural’ Gene Mutation May Offer Way of Treating Sickle Cell Disease, Study Says
  • Sema4 and Helix Launch CarrierCheck, a Genetic Screen of 67 Hereditary Diseases
  • Quest Diagnostics Launches Genetic Test to Assess Risk for Sickle Cell Anemia, Other Inherited Disorders
  • Localized Nerve Anesthesia a Viable Option for Pain Control in Pediatric SCD Patients, Study Suggests
  • Global Blood Expands Sickle Cell Study to Include Kids Ages 6-11
  • FDA Approves Endari, 1st Sickle Cell Treatment in Almost 20 Years, for Patients Age 5 and Older
  • Researchers Identify Genetic Predictors of Sickle Cell Anemia-Related Complications
  • European Agency Grants PRIME Access to GBT440 Therapy for Treatment of SCD
  • Chip-based Models Mimic Organs to Advance Understanding of Sickle Cell Disease